Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability

International Journal of Pharmaceutics

Volumn 423, Issue 2, 2012, Pages 554-561

  Benival, Derajram M ^a   Devarajan, Padma V ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Doxorubicin hydrochloride; Drug loading; Gantrez; Lipid nanocarrier; Lipomer; Oral bioavailability

Indexed keywords

CATALASE; DOXORUBICIN; GANTREZ COPOLYMER; LIPID POLYMER HYBRID NANOPARTICLE; MALONALDEHYDE; NANOCARRIER; POLYGLYCERYL 6 DISTEARATE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SCREENING; FEMALE; FREEZE DRYING; NANOFABRICATION; NANOPRECIPITATION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CATALASE; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; GLYCEROL; HEART; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KIDNEY; LIPIDS; MALEATES; MALONDIALDEHYDE; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCARDIUM; NANOPARTICLES; NANOTECHNOLOGY; OSMOLAR CONCENTRATION; OXIDATIVE STRESS; POLYMERS; POLYVINYLS; POWDER DIFFRACTION; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SUPEROXIDE DISMUTASE; TECHNOLOGY, PHARMACEUTICAL;

EID: 84856510684     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.11.035     Document Type: Article

References (41)

1. M. Aprahamian, C. Michel, W. Humbert, J.P. Devissaguet, and C. Damg Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine Biol. Cell 61 1987 69 76 (Pubitemid 18046633)
2. A. Bargoni, R. Cavalli, G.P. Zara, A. Fundar, O. Caputo, and M.R. Gasco Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II - Tissue distribution Pharmacol. Res. 43 2001 497 502 (Pubitemid 32578867)
3. L. Bromberg Intelligent hydrogels for the oral delivery of chemotherapeutics Expert Opin. Drug Deliv. 2 2005 1003 1013 (Pubitemid 41701200)
4. L. Bromberg, and V. Alakhov Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers J. Control. Release 88 2003 11 22 (Pubitemid 36175538)
5. R. Cavalli, O. Caputo, and M.R. Gasco Solid lipospheres of doxorubicin and idarubicin Int. J. Pharm. 89 1993 R9 R12
6. B.A. Chabner, P.C. Amrein, B.J. Druker, M.D. Michaelson, C.S. Mitsiades, P.E. Goss, D.P. Ryan, S. Ramachandra, P.G. Richardson, J.G. Supka, and W.H. Wilson Antineoplastic agents L.L. Brunton, J.S. Lazo, K.L. Parker, Goodman & Gilman's The Pharmacological Basis of Therapeutics 2006 Mc Graw Hill New York 1357 1359
7. S. Choi, S. Shin, and J. Choi Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin Arch. Pharm. Res. 34 2011 309 315
8. C. Damag, C. Michel, M. Aprahamian, and P. Couvreur New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier Diabetes 37 1988 246 251 (Pubitemid 18066612)
9. P.V. Devarajan, A.B. Jindal, R.R. Patil, F. Mulla, R.V. Gaikwad, and A. Samad Particle shape: a new design parameter for passive targeting in splenotropic drug delivery J. Pharm. Sci. 99 2010 2576 2581
10. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley, and T.R. Tice Controlled vaccine release in the gut associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches J. Control. Release 11 1990 205 214 (Pubitemid 20070098)
11. A.T. Florence Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discov. Today: Technol. 2 2005 75 81 (Pubitemid 40946311)
12. M. Garcia-Fuentes, D. Torres, and M.J. Alonso New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin Int. J. Pharm. 296 2005 122 132 (Pubitemid 40693381)
13. S.A. Guhagarkar, R.V. Gaikwad, A. Samad, V.C. Malshe, and P.V. Devarajan Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting Int. J. Pharm. 401 2010 113 122
14. V. Hoffart, A. Lamprecht, P. Maincent, T. Lecompte, C. Vigneron, and N. Ubrich Oral bioavailability of a low molecular weight heparin using a polymeric delivery system J. Control. Release 113 2006 38 42 (Pubitemid 43818166)
15. D. Hou, C. Xie, K. Huang, and C. Zhu The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 2003 1781 1785 (Pubitemid 36184733)
16. D.D. Joel, J.A. Laissue, and M.E. LeFevre Distribution and fate of ingested carbon particles in mice J. Reticuloendothel. Soc. 24 1978 477 487 (Pubitemid 9105147)
17. D.R. Kalaria, G. Sharma, V. Beniwal, and M.N. Ravi Kumar Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats Pharm. Res. 26 2009 492 501
18. W. Ke, Y. Zhao, R. Huang, C. Jiang, and Y. Pei Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system J. Pharm. Sci. 97 2008 2208 2216
19. A.M. Layre, P. Couvreur, H. Chacun, C. Aymes-Chodur, N.E. Ghermani, J. Poupaert, J. Richard, D. Requier, and R. Gref Busulfan loading into poly(alkyl cyanoacrylate) nanoparticles: physico-chemistry and molecular modeling J. Biomed. Mater. Res. B: Appl. Biomater. 79 2006 254 262 (Pubitemid 44652049)
20. H. Li, X. Zhao, Y. Ma, G. Zhai, L. Li, and H. Lou Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles J. Control. Release 133 2009 238 244
21. Z. Ma, T.M. Lim, and L.Y. Lim Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats Int. J. Pharm. 293 2005 271 280 (Pubitemid 40381099)
22. H. Maeda SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy Adv. Drug Deliver. Rev. 6 1991 181 202
23. E. Mathiowitz, J.S. Jacob, Y.S. Jong, G.P. Carino, D.E. Chickering, P. Chaturvedi, C.A. Santos, K. Vijayaraghavan, S. Montgomery, M. Bassett, and C. Morrell Biologically erodable microspheres as potential oral drug delivery systems Nature 386 1997 410 414 (Pubitemid 27154483)
24. K. Matsuno, T. Schaffner, H.A. Gerber, C. Ruchti, M.W. Hess, and H. Cottier Uptake by enterocytes and subsequent translocation to internal organs, eg, the thymus, of Percoll microspheres administered per os to suckling mice J. Reticuloendothel. Soc. 33 1983 263 273 (Pubitemid 13082364)
25. D.T. O'Hagan Intestinal translocation of particulates - implications for drug and antigen delivery Adv. Drug Deliver. Rev. 5 1990 265 285 (Pubitemid 20333028)
26. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 35l 358l
27. R.R. Patil, S.A. Guhagarkar, and P.V. Devarajan Engineered nanocarriers of doxorubicin: a current update Crit. Rev. Ther. Drug Carrier Syst. 25 2008 1 61 (Pubitemid 351363756)
28. R.R. Patil, R.V. Gaikwad, A. Samad, and P.V. Devarajan Role of lipids in enhancing splenic uptake of polymer-lipid (LIPOMER) nanoparticles J. Biomed. Nanotechnol. 4 2008 359 366
29. A. Saez, M. Guzman, J. Molpeceres, and M.R. Aberturas Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs Eur. J. Pharm. Biopharm. 50 2000 379 387
30. H.H. Salman, C. Gamazo, M.A. Campanero, and J.M. Irache Salmonella-like bioadhesive nanoparticles J. Control. Release 106 2005 1 13 (Pubitemid 41140076)
31. 12-Gantrez nanoparticles Pharm. Res. 25 2008 2859 2868
32. H.H. Salman, C. Gamazo, M.A. Campanero, and J.M. Irache Bioadhesive mannosylated nanoparticles for oral drug delivery J. Nanosci. Nanotechnol. 6 2006 3203 3209 (Pubitemid 44580001)
33. E. Sanders, and C.T. Ashworth A study of particulate intestinal absorption and hepatocellular uptake: use of polystyrene latex particles Exp. Cell Res. 22 1961 137 145
34. R.K. Subedi, K.W. Kang, and H. Choi Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin Eur. J. Pharm. Sci. 37 2009 508 513
35. V.T. Thakkar, P.A. Shah, T.G. Soni, M.Y. Parmar, M.C. Gohel, and T.R. Gandhi Goodness-of-fit model-dependent approach for release kinetics of levofloxacin hemihydrates floating tablet Dissolution Technol. 2009 35 39
36. G. Volkheimer, F.H. Schulz, I. Aurich, S. Strauch, K. Beuthin, and H. Wendlandt Persorption of particles Digestion 1 1968 78 80
37. C.L. Wells, M.A. Maddaus, S.L. Erlandsen, and R.L. Simmons Evidence for the phagocytic transport of intestinal particles in dogs and rats Infect. Immun. 56 1988 278 282 (Pubitemid 18032166)
38. H.L. Wong, R. Bendayan, A.M. Rauth, and X.Y. Wu Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers J. Pharm. Sci. 93 2004 1993 2008 (Pubitemid 39045481)
39. H.L. Wong, A.M. Rauth, R. Bendayan, J.L. Manias, M. Ramaswamy, Z. Liu, S.Z. Erhan, and X.Y. Wu A new polymerylipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells Pharm. Res. 23 2006 1574 1585 (Pubitemid 43993820)
40. M.F. Xu, P.L. Tang, Z.M. Qian, and M. Ashraf Effects by doxorubicin on the myocardium are mediated by oxygen free radicals Life Sci. 68 2001 889 901 (Pubitemid 32168065)
41. G.P. Zara, A. Bargoni, R. Cavalli, A. Fundaro', D. Vighetto, and M.R. Gasco Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats J. Pharm. Sci. 91 2002 1324 1333 (Pubitemid 34651194)